These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6601707)

  • 61. [The effect of zymosan activated blood plasma (products of the activation of complement system) on heart function].
    Shebeko VI; Solodkov AP; Rodionov IuIa
    Dokl Akad Nauk SSSR; 1989; 309(3):753-6. PubMed ID: 2630250
    [No Abstract]   [Full Text] [Related]  

  • 62. Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection.
    Kernodle DS; Gates H; Kaiser AB
    Antimicrob Agents Chemother; 1998 Mar; 42(3):545-9. PubMed ID: 9517930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Studies on the mechanism of PMN activation. II. By triggering the alternative pathway of complement activation.
    Müller J; Botzenhardt U; Lemmel EM
    Blut; 1982 Jul; 45(1):13-22. PubMed ID: 6177367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activation of human complement by rat peritoneal mast cells and its inhibition by a rat serum factor.
    Arizono N; Nishimukai H; Nakao S; Takeoka O
    Agents Actions; 1988 Jun; 24(1-2):73-9. PubMed ID: 3136626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alternative pathway complement activation induces reductions in effective hepatic blood flow.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Curr Surg; 1987; 44(4):304-8. PubMed ID: 3665580
    [No Abstract]   [Full Text] [Related]  

  • 66. Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model.
    Kaiser AB; Kernodle DS
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2449-51. PubMed ID: 9736583
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice.
    Őrfi E; Mészáros T; Hennies M; Fülöp T; Dézsi L; Nardocci A; Rosivall L; Hamar P; Neun BW; Dobrovolskaia MA; Szebeni J; Szénási G
    Int J Nanomedicine; 2019; 14():1563-1573. PubMed ID: 30880965
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9).
    Kashyap A; Saha K; Sehgal VN
    Int J Immunopharmacol; 1992 Nov; 14(8):1409-14. PubMed ID: 1464472
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis.
    Cisneros RL; Gibson FC; Tzianabos AO
    Infect Immun; 1996 Jun; 64(6):2201-5. PubMed ID: 8675327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A screening test for modified hemoglobin blood substitutes before clinical use: based on C3a complement activation in human plasma.
    Chang TM; Lister C
    Biomater Artif Cells Artif Organs; 1990; 18(5):693-701. PubMed ID: 2099226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inability of rat anaphylatoxin to induce histamine release in rats.
    Konno S; Tsurufuji S
    Jpn J Pharmacol; 1985 Jun; 38(2):185-93. PubMed ID: 2411984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complement activation of electrogenic ion transport in isolated rat colon.
    McCole DF; Otti B; Newsholme P; Baird AW
    Biochem Pharmacol; 1997 Nov; 54(10):1133-7. PubMed ID: 9464456
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibitory effects of a novel synthetic protease inhibitor, FUT-175, on the paw edema in rats and zymosan-induced complement activation in vitro.
    Sato T; Ino Y; Koshiyama Y; Motoyoshi A; Oda M; Iwaki M
    Jpn J Pharmacol; 1986 Dec; 42(4):587-9. PubMed ID: 3807057
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of a protein-bound polysaccharide PS-K on the complement system.
    Kato H; Yokoe N; Takemura S; Yoshikawa T; Furukawa Y; Kondo M
    Res Exp Med (Berl); 1983; 182(2):85-94. PubMed ID: 6867480
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [A peptide (a magnesium salt of N-acetyl (alpha, beta)-aspartyl-glutamic acid). Demonstration of the protection against local cellular destruction induced by in situ complement activation].
    Chevance LG; Etiévant M
    J Pharmacol; 1986; 17(4):676-85. PubMed ID: 3560976
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunologically active O6-branched (1-->3)-beta-glucan from the lichen Thamnolia vermicularis var. subuliformis.
    Olafsdottir ES; Omarsdottir S; Paulsen BS; Wagner H
    Phytomedicine; 2003 May; 10(4):318-24. PubMed ID: 12809362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhancement of interleukin-1 and interleukin-2 production by soluble glucan.
    Sherwood ER; Williams DL; McNamee RB; Jones EL; Browder IW; Di Luzio NR
    Int J Immunopharmacol; 1987; 9(3):261-7. PubMed ID: 3497113
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pre-clinical safety evaluation of soluble glucan.
    Williams DL; Sherwood ER; Browder IW; McNamee RB; Jones EL; Di Luzio NR
    Int J Immunopharmacol; 1988; 10(4):405-14. PubMed ID: 3262594
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dietary β-glucan enhances the contents of complement component 3 and factor B in eggs of zebrafish.
    Jiang C; Wang P; Li M; Liu S; Zhang S
    Dev Comp Immunol; 2016 Dec; 65():107-113. PubMed ID: 27375187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inflammatory responses by inhalation of endotoxin and (1-->3)-beta-D-glucan.
    Rylander R; Fogelmark B
    Am J Ind Med; 1994 Jan; 25(1):101-2. PubMed ID: 8116629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.